Related references
Note: Only part of the references are listed.Oral Therapies for Multiple Sclerosis
Simon Faissner et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab
Jennifer Petrillo et al.
JOURNAL OF NEURO-OPHTHALMOLOGY (2019)
Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors
Kelsey A. Rankin et al.
JOURNAL OF NEUROSCIENCE (2019)
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration
Dmitri Lodygin et al.
NATURE (2019)
Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity
Wenjing Yi et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10
Olga L. Rojas et al.
CELL (2019)
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
J. William L. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis A Randomized Clinical Trial
Richard K. Burt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
Yvonne Naegelin et al.
JAMA NEUROLOGY (2019)
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Hans Lassmann
FRONTIERS IN IMMUNOLOGY (2019)
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Simon Faissner et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Simon Faissner et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
Simon Faissner et al.
CNS DRUGS (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
Raja Kapoor et al.
LANCET NEUROLOGY (2018)
Microglial control of astrocytes in response to microbial metabolites
Veit Rothhammer et al.
NATURE (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis
Monica Kurte et al.
FRONTIERS IN IMMUNOLOGY (2018)
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
R. J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging
Assunta Dal-Bianco et al.
ACTA NEUROPATHOLOGICA (2017)
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Ari J. Green et al.
LANCET (2017)
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid et al.
LANCET NEUROLOGY (2017)
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
Dennis Chan et al.
LANCET NEUROLOGY (2017)
Targets of therapy in progressive MS
Hans Lassmann
MULTIPLE SCLEROSIS JOURNAL (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Remyelination therapies: a new direction and challenge in multiple sclerosis
Jason R. Plemel et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
PREGABALIN ENHANCES MYELIN REPAIR AND ATTENUATES GLIAL ACTIVATION IN LYSOLECITHIN-INDUCED DEMYELINATION MODEL OF RAT OPTIC CHIASM
Danyal Daneshdoust et al.
NEUROSCIENCE (2017)
Wellness and the Role of Comorbidities in Multiple Sclerosis
Brandon P. Moss et al.
NEUROTHERAPEUTICS (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
L. M. Metz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
Simon Faissner et al.
NATURE COMMUNICATIONS (2017)
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Paolo A. Muraro et al.
JAMA NEUROLOGY (2017)
Targets of therapy in progressive MS
Hans Lassmann
MULTIPLE SCLEROSIS JOURNAL (2017)
Lipoic acid in secondary progressive MS A randomized controlled pilot trial
Rebecca Spain et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
Disease-modifying treatments for multiple sclerosis - a review of approved medications
O. Torkildsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
E. L. MacMillan et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
E. L. MacMillan et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis
Robert J. Fox et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Minocycline added to subcutaneous interferon-1a in multiple sclerosis: randomized RECYCLINE study
P. S. Sorensen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis
Joachim Burman et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis
Alice Valentin-Torres et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
Rhian Raftopoulos et al.
LANCET NEUROLOGY (2016)
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
Ayman Tourbah et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
MS arising during Tocilizumab therapy for rheumatoid arthritis
Philippe Beauchemin et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
A polarizing question: do M1 and M2 microglia exist?
Richard M. Ransohoff
NATURE NEUROSCIENCE (2016)
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
Ayman Tourbah et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
MS arising during Tocilizumab therapy for rheumatoid arthritis
Philippe Beauchemin et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Ongoing Oxidative stress causes subclinical neuronal Dysfunction in the recovery Phase of EAE
Helena Radbruch et al.
FRONTIERS IN IMMUNOLOGY (2016)
Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
Mika Komori et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants
Kevin Blauth et al.
ACTA NEUROPATHOLOGICA (2015)
Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis
Mika Komori et al.
ANNALS OF NEUROLOGY (2015)
Dynamic Changes of Microglia/Macrophage M1 and M2 Polarization in Theiler's Murine Encephalomyelitis
Vanessa Herder et al.
BRAIN PATHOLOGY (2015)
Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis
Simon Zhornitsky et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis
Carine Savarin et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS
Dinesh C. Joshi et al.
JOURNAL OF NEUROSCIENCE (2015)
Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
Marcus W. Koch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Progressive multiple sclerosis 3 Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
Daniel Ontaneda et al.
LANCET NEUROLOGY (2015)
Progressive multiple sclerosis 1 Pathological mechanisms in progressive multiple sclerosis
Don H. Mahad et al.
LANCET NEUROLOGY (2015)
Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation
Juan G. Zarruk et al.
NEUROBIOLOGY OF DISEASE (2015)
Autologous hematopoietic stem cell transplantation in multiple sclerosis A phase II trial
Giovanni L. Mancardi et al.
NEUROLOGY (2015)
Mitochondrial DNA sequence variation in multiple sclerosis
Gregory J. Tranah et al.
NEUROLOGY (2015)
Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy
Rui Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial
Claire M. Rice et al.
TRIALS (2015)
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis Is Intrathecal Anti-CD20 a Therapeutic Option?
Mahboobeh Fereidan-Esfahani et al.
JAMA NEUROLOGY (2015)
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized inflammation
Laure Michel et al.
FRONTIERS IN IMMUNOLOGY (2015)
Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration
Daniel May de Oliveira et al.
INFLAMMOPHARMACOLOGY (2015)
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
Anders Svenningsson et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Early Netrin-1 Expression Impairs Central Nervous System Remyelination
Vanja Tepavcevic et al.
ANNALS OF NEUROLOGY (2014)
Second generation S1P pathway modulators: Research strategies and clinical developments
Marc Bigaud et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells
Narasimhulu Simma et al.
CELL COMMUNICATION AND SIGNALING (2014)
Demyelinizing neurological disease after treatment with tumor necrosis factor alpha-inhibiting agents in a rheumatological outpatient clinic: description of six cases
Ali Theibich et al.
CLINICAL RHEUMATOLOGY (2014)
Human CNS immune senescence and neurodegeneration
Wolfgang J. Streit et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Effects of Dextromethorphan on Glial Cell Function: Proliferation, Maturation, and Protection from Cytotoxic Molecules
Robert P. Lisak et al.
GLIA (2014)
Astrocyte galectin-9 potentiates microglial TNF secretion
Andrew J. Steelman et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
Lukas Haider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
N-Methyl-d-Aspartate Receptor Blockade Is Neuroprotective in Experimental Autoimmune Optic Neuritis
Kurt-Wolfram Sühs et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab
Manabu Araki et al.
Modern Rheumatology (2014)
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
Jeremy Chataway et al.
LANCET (2014)
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
Ludwig Kappos et al.
LANCET NEUROLOGY (2014)
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Lior Mayo et al.
NATURE MEDICINE (2014)
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Feng Mei et al.
NATURE MEDICINE (2014)
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Manuel A. Friese et al.
NATURE REVIEWS NEUROLOGY (2014)
Iron in multiple sclerosis: roles in neurodegeneration and repair
Erin Stephenson et al.
NATURE REVIEWS NEUROLOGY (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
TNF and Increased Intracellular Iron Alter Macrophage Polarization to a Detrimental M1 Phenotype in the Injured Spinal Cord
Antje Kroner et al.
NEURON (2014)
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models
Catherine Diamante Sorbara et al.
NEURON (2014)
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis
Madeleine White et al.
PLOS ONE (2014)
Modulation of Glutamate Transport and Receptor Binding by Glutamate Receptor Antagonists in EAE Rat Brain
Grzegorz Sulkowski et al.
PLOS ONE (2014)
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study
Katrin Strassburger-Krogias et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2014)
Gene Therapy With Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis
Venu Talla et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
Jonathan Q. Tran et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Iron and Neurodegeneration in the Multiple Sclerosis Brain
Simon Hametner et al.
ANNALS OF NEUROLOGY (2013)
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride
Tarunya Arun et al.
BRAIN (2013)
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis
David Paling et al.
BRAIN (2013)
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination
Josephine M. J. Stoffels et al.
BRAIN (2013)
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders
Ankita Mehta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis
Grzegorz Sulkowski et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis
Roberta Magliozzi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2013)
A regenerative approach to the treatment of multiple sclerosis
Vishal A. Deshmukh et al.
NATURE (2013)
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Veronique E. Miron et al.
NATURE NEUROSCIENCE (2013)
OPINION Pathophysiology of the brain extracellular matrix: a new target for remyelination
Lorraine W. Lau et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17-and Activated B-Cells and Correlates with Progression
Jeppe Romme Christensen et al.
PLOS ONE (2013)
Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans
Anders Tisell et al.
PLOS ONE (2013)
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis
Graham R. Campbell et al.
ACTA NEUROPATHOLOGICA (2012)
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
Sung R. Choi et al.
BRAIN (2012)
Iron Efflux from Astrocytes Plays a Role in Remyelination
Katrin Schulz et al.
JOURNAL OF NEUROSCIENCE (2012)
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
Peter Connick et al.
LANCET NEUROLOGY (2012)
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Youngjin Lee et al.
NATURE (2012)
Progressive multiple sclerosis: pathology and pathogenesis
Hans Lassmann et al.
NATURE REVIEWS NEUROLOGY (2012)
Will the real multiple sclerosis please stand up?
Peter K. Stys et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Mitochondrial DNA Deletions and Neurodegeneration in Multiple Sclerosis
Graham R. Campbell et al.
ANNALS OF NEUROLOGY (2011)
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model
Sandra Vergo et al.
BRAIN (2011)
Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis
Jessica L. Zambonin et al.
BRAIN (2011)
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
Ralf A. Linker et al.
BRAIN (2011)
Oxidative damage in multiple sclerosis lesions
Lukas Haider et al.
BRAIN (2011)
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell et al.
BRAIN (2011)
Simvastatin Inhibits IFN Regulatory Factor 4 Expression and Th17 Cell Differentiation in CD4+ T Cells Derived from Patients with Multiple Sclerosis
Xin Zhang et al.
JOURNAL OF IMMUNOLOGY (2011)
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Ivana Nikic et al.
NATURE MEDICINE (2011)
Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord
Olga V. Chechneva et al.
NEUROBIOLOGY OF DISEASE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Meningeal T Cells Associate with Diffuse Axonal Loss in Multiple Sclerosis Spinal Cords
Geraldine Androdias et al.
ANNALS OF NEUROLOGY (2010)
A Gradient of Neuronal Loss and Meningeal Inflammation in Multiple Sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2010)
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Laura Piccio et al.
ARCHIVES OF NEUROLOGY (2010)
Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing-Progressive Multiple Sclerosis
C. M. Rice et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Demyelination Increases Axonal Stationary Mitochondrial Size and the Speed of Axonal Mitochondrial Transport
Sumiko Kiryu-Seo et al.
JOURNAL OF NEUROSCIENCE (2010)
Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
Maarten E. Witte et al.
MITOCHONDRION (2010)
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor et al.
LANCET NEUROLOGY (2010)
Myelination and support of axonal integrity by glia
Klaus-Armin Nave
NATURE (2010)
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
Yoonsang Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Rituximab in Patients with Primary Progressive Multiple Sclerosis Results of a Randomized Double-Blind Placebo-Controlled Multicenter Trial
Kathleen Hawker et al.
ANNALS OF NEUROLOGY (2009)
Mitochondrial changes within axons in multiple sclerosis
Don J. Mahad et al.
BRAIN (2009)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Oligodendrocytes and Myelination: The Role of Iron
Bozho Todorich et al.
GLIA (2009)
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
Bernadette Poellinger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Enhanced number and activity of mitochondria in multiple sclerosis lesions
Maarten E. Witte et al.
JOURNAL OF PATHOLOGY (2009)
Glatiramer acetate in combination with minocycline in patients with relapsing-remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial
L. M. Metz et al.
MULTIPLE SCLEROSIS (2009)
Remyelination protects axons from demyelination-associated axon degeneration
K. A. Irvine et al.
BRAIN (2008)
Mitochondrial defects in acute multiple sclerosis lesions
Don Mahad et al.
BRAIN (2008)
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
R. Zivadinov et al.
NEUROLOGY (2008)
Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis - current status
Stephen G. Waxman
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system
Manuel A. Friese et al.
NATURE MEDICINE (2007)
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis
Sha Mi et al.
NATURE MEDICINE (2007)
Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Hirohide Sawada et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
D. H. Miller et al.
NEUROLOGY (2007)
White matter plasticity and enhanced remyelination in the maternal CNS
Christopher Gregg et al.
JOURNAL OF NEUROSCIENCE (2007)
Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis
Sonja Hochmeister et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
J Greenwood et al.
NATURE REVIEWS IMMUNOLOGY (2006)
S1P inhibits gap junctions in astrocytes:: involvement of Gi and Rho GTPase/ROCK
N Rouach et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Effective combination of minocycline and interferon-β in a model of multiple sclerosis
F Giuliani et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction
F Giuliani et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Glutamate inhibition in MS: The neuroprotective properties of riluzole
J Killestein et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
LINGO-1 negatively regulates myelination by oligodendrocytes
S Mi et al.
NATURE NEUROSCIENCE (2005)
HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis
AS Paintlia et al.
FASEB JOURNAL (2005)
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS
MJ Craner et al.
GLIA (2005)
Additive effect of the combination of glatiramer acetate and minocycline in a model of MS
F Giuliani et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)
SJ Wang et al.
NEUROSCIENCE (2004)
Molecular changes in neurons in multiple sclerosis:: Altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na+/Ca2+ exchanger
MJ Craner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis
Y Gilgun-Sherki et al.
BRAIN RESEARCH (2003)
Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats
JL Beard et al.
DEVELOPMENTAL NEUROSCIENCE (2003)
Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation
YX Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study
NF Kalkers et al.
MULTIPLE SCLEROSIS (2002)
Targeting leukocyte MMPs and transmigration - Minocycline as a potential therapy for multiple sclerosis
V Brundula et al.
BRAIN (2002)
A subset of newly synthesized polypeptides in mitochondria from human endothelial cells exposed to hydroperoxide stress
A Mitsumoto et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis
C Beeton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts
A Pébay et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes
RD Azbill et al.
BRAIN RESEARCH (2000)
Acute axonal injury in multiple sclerosis -: Correlation with demyelination and inflammation
A Bitsch et al.
BRAIN (2000)
Glutamate excitotoxicity in a model of multiple sclerosis
D Pitt et al.
NATURE MEDICINE (2000)
Share Paper
